Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

1.

Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort.

Paddock S, Laje G, Charney D, Rush AJ, Wilson AF, Sorant AJ, Lipsky R, Wisniewski SR, Manji H, McMahon FJ.

Am J Psychiatry. 2007 Aug;164(8):1181-8.

PMID:
17671280
[PubMed - indexed for MEDLINE]
2.

Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder.

Kato M, Serretti A.

Mol Psychiatry. 2010 May;15(5):473-500. doi: 10.1038/mp.2008.116. Epub 2008 Nov 4. Review.

PMID:
18982004
[PubMed - indexed for MEDLINE]
3.

Pharmacogenetics of psychotropic drug response.

Malhotra AK, Murphy GM Jr, Kennedy JL.

Am J Psychiatry. 2004 May;161(5):780-96. Review.

PMID:
15121641
[PubMed - indexed for MEDLINE]
4.

Pharmacogenetics of major depression: insights from level 1 of the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial.

Lekman M, Paddock S, McMahon FJ.

Mol Diagn Ther. 2008;12(5):321-30. Review.

PMID:
18803430
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Genetic screening for SSRI drug response among those with major depression: great promise and unseen perils.

Rasmussen-Torvik LJ, McAlpine DD.

Depress Anxiety. 2007;24(5):350-7. Review.

PMID:
17096399
[PubMed - indexed for MEDLINE]
6.

Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study.

Fava M, Rush AJ, Trivedi MH, Nierenberg AA, Thase ME, Sackeim HA, Quitkin FM, Wisniewski S, Lavori PW, Rosenbaum JF, Kupfer DJ.

Psychiatr Clin North Am. 2003 Jun;26(2):457-94, x. Review.

PMID:
12778843
[PubMed - indexed for MEDLINE]
7.

Do glutamatergic agents represent a new class of antidepressant drugs? Part 2.

Sanacora G.

J Clin Psychiatry. 2009 Nov;70(11):1604-5. doi: 10.4088/JCP.09ac05757blu. Review. No abstract available.

PMID:
20031105
[PubMed - indexed for MEDLINE]
8.

Genetic studies of drug response and side effects in the STAR*D study, part 1.

Garriock HA, Hamilton SP.

J Clin Psychiatry. 2009 Aug;70(8):1186-7. doi: 10.4088/JCP.09ac05519. Review. No abstract available.

PMID:
19758527
[PubMed - indexed for MEDLINE]
9.

[Possibility of a pharmacogenetic approach for prediction and personalized medication in major depressive disorder treatment].

Kato M.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2010 Apr;30(2):83-92. Review. Japanese.

PMID:
20491282
[PubMed - indexed for MEDLINE]
10.

Pharmacogenomics with antidepressants in the STAR*D study.

Lin E, Chen PS.

Pharmacogenomics. 2008 Jul;9(7):935-46. doi: 10.2217/14622416.9.7.935. Review.

PMID:
18597655
[PubMed - indexed for MEDLINE]
11.

Genome-wide association studies of antidepressant outcome: a brief review.

Laje G, McMahon FJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15;35(7):1553-7. doi: 10.1016/j.pnpbp.2010.11.031. Epub 2010 Nov 27. Review.

PMID:
21115088
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Pharmacogenetic studies of antidepressant response: how far from the clinic?

Perlis RH.

Psychiatr Clin North Am. 2007 Mar;30(1):125-38. Review.

PMID:
17362808
[PubMed - indexed for MEDLINE]
13.

Pharmacologic approaches to treatment resistant depression: a re-examination for the modern era.

Philip NS, Carpenter LL, Tyrka AR, Price LH.

Expert Opin Pharmacother. 2010 Apr;11(5):709-22. doi: 10.1517/14656561003614781. Review.

PMID:
20151847
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Individualized medicine - implementation of pharmacogenetic diagnostics in antidepressant drug treatment of major depressive disorders.

Kirchheiner J, Bertilsson L, Bruus H, Wolff A, Roots I, Bauer M.

Pharmacopsychiatry. 2003 Nov;36 Suppl 3:S235-43. Review.

PMID:
14677085
[PubMed - indexed for MEDLINE]
15.

The pharmacogenomics of selective serotonin reuptake inhibitors.

Serretti A, Artioli P.

Pharmacogenomics J. 2004;4(4):233-44. Review.

PMID:
15111987
[PubMed - indexed for MEDLINE]
16.

From molecular biology to pharmacogenetics: a review of the literature on antidepressant treatment and suggestions of possible candidate genes.

Serretti A, Artioli P.

Psychopharmacology (Berl). 2004 Aug;174(4):490-503. Epub 2004 Mar 2. Review.

PMID:
14997279
[PubMed - indexed for MEDLINE]
17.

Role of pharmacogenomics in individualising treatment with SSRIs.

Mancama D, Kerwin RW.

CNS Drugs. 2003;17(3):143-51. Review.

PMID:
12617694
[PubMed - indexed for MEDLINE]
18.

Pharmacogenetics of antidepressant response.

Keers R, Aitchison KJ.

Expert Rev Neurother. 2011 Jan;11(1):101-25. doi: 10.1586/ern.10.186. Review.

PMID:
21158559
[PubMed - indexed for MEDLINE]
19.

Focus on The 5-HT1A receptor: emerging role of a gene regulatory variant in psychopathology and pharmacogenetics.

Lesch KP, Gutknecht L.

Int J Neuropsychopharmacol. 2004 Dec;7(4):381-5. Review.

PMID:
15683551
[PubMed - indexed for MEDLINE]
20.

Pharmacogenetics in the treatment of depression: pharmacodynamic studies.

Serretti A, Artioli P, Quartesan R.

Pharmacogenet Genomics. 2005 Feb;15(2):61-7. Review.

PMID:
15861029
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk